,Date,Title,Url
0,2017-01-04,fnRASSI영진약품003520554상승,http://www.fnnews.com/news/201701041035351639
1,2017-01-04,fnRASSI영진약품003520전일대비52상승,http://www.fnnews.com/news/201701041510192257
2,2017-01-06,특징주영진약품외인매도에도꿋꿋,http://www.g-enews.com/ko-kr/news/article/news_all/201701060925151716174_1/article.html
3,2017-01-06,영진약품유케이케미팜항생제키트주사제공동판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=70764
4,2017-01-06,영진약품유케이케미팜키트주사제공동판매,http://medipana.com/news/news_viewer.asp?NewsNum=193739&MainKind=A&NewsKind=5&vCount=12&vKind=1
5,2017-01-06,영진약품유케이케미팜일체형항생제키트주사제공동판매,http://www.monews.co.kr/news/articleView.html?idxno=96428
6,2017-01-06,영진약품유케이케미팜일체형항생제키트주사제판매,http://www.joseilbo.com/news/news_read.php?uid=313444&class=27&grp=
7,2017-01-06,영진약품유케이케미팜일체형항생제키트주사제공동판매계약체결,http://www.fnnews.com/news/201701061618172583
8,2017-01-09,빅데이터MSI시장심리톱5롯데쇼핑삼성전자영진약품LG생활건강신한지주,http://www.newsis.com/view/?id=NISX20170109_0014628042&cID=10401&pID=10400
9,2017-01-10,영진약품화성에바이오허브조성,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1296667
10,2017-01-13,특징주영진약품외인러브콜하루만에기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201701130921372029558_1/article.html
11,2017-01-16,영진약품공업KTG생명과학합병완료,http://www.mt.co.kr/view/mtview.php?type=1&no=2017011615154416162&outlink=1
12,2017-01-16,영진약품KTG생명과학합병종료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1442408
13,2017-01-16,영진약품KTG생명과학합병완료,http://www.cstimes.com/news/articleView.html?idxno=236039
14,2017-01-16,영진약품공업KTG생명과학합병종료,http://www.asiatoday.co.kr/view.php?key=20170116010010123
15,2017-01-16,영진약품KTG생명과학합병종료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202833
16,2017-01-18,영진약품신약개발속도글로벌잭팟성큼,http://www.newspim.com/news/view/20170118000315
17,2017-01-19,빅데이터MSI시장심리톱5SK현대상선LG생활건강현대건설영진약품,http://www.newsis.com/view/?id=NISX20170119_0014651071&cID=10427&pID=10400
18,2017-01-19,영진약품공업작년4분기적자전환,http://view.asiae.co.kr/news/view.htm?idxno=2017011911055689349
19,2017-01-19,영진약품공업4Q영업손실65억원전년比적자전환,http://www.mt.co.kr/view/mtview.php?type=1&no=2017011911045040205&outlink=1
20,2017-01-19,영진약품공업4분기적자전환,http://www.sedaily.com/NewsView/1OAVOHAZSB
21,2017-01-19,영진약품작년4분기영업손실6억원전년比적자전환,http://biz.chosun.com/site/data/html_dir/2017/01/19/2017011901125.html
22,2017-01-19,영진약품공업작년4분기영업손실로적자전환,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170119088900008&did=1195m
23,2017-01-19,영진약품작년4분기6억4600만원영업손실적자전환,http://www.asiatoday.co.kr/view.php?key=20170119010012545
24,2017-01-19,영진약품작년4분기영업손64억적자전환,http://news.heraldcorp.com/view.php?ud=20170119000594
25,2017-01-19,영진약품공업작년4Q영업적자6억적자전환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1444139
26,2017-01-19,공시영진약품공업4Q영업손실6억원으로적자전환,http://www.newsway.co.kr/view.php?tp=1&ud=2017011911344584094
27,2017-01-19,영진약품공업작년4분기적자전환영업손실64억,http://betanews.heraldcorp.com:8080/article/672079.html
28,2017-01-19,영진약품4Q영업손실6억원적자전환,http://www.newspim.com/news/view/20170119000226
29,2017-01-19,영진약품공업작년4분기영업손실로적자전환,http://www.cstimes.com/news/articleView.html?idxno=236392
30,2017-01-19,영진약품공업4분기적자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=03949126615799360
31,2017-01-19,영진약품작년4분기영업이익6억적자,http://www.kukinews.com/news/article.html?no=425755
32,2017-01-19,영진약품지난해1931억매출로135성장,http://medipana.com/news/news_viewer.asp?NewsNum=194295&MainKind=A&NewsKind=5&vCount=12&vKind=1
33,2017-01-20,특징주영진약품4분기적자전환충격벗어나나외인러브콜하루만에기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201701200915237061659_1/article.html
34,2017-01-20,LG화학영진약품등연이은제약계합병기대반우려반,http://www.ajunews.com/view/20170119113315018
35,2017-01-26,유가증권메모26일보통주추가상장영진약품합병등,http://stock.hankyung.com/news/app/newsview.php?aid=2017012632251
36,2017-02-03,영진약품메디포트고용량비타민D의약품공동판매계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203258
37,2017-02-03,영진약품메디포트고용량비타민D공동판매,http://medipana.com/news/news_viewer.asp?NewsNum=194816&MainKind=A&NewsKind=5&vCount=12&vKind=1
38,2017-02-03,영진약품메디포트고용량비타민D판매계약체결,http://www.dt.co.kr/contents.html?article_no=2017020302109976029004
39,2017-02-03,영진약품D3베이스공동판매계약체결,http://www.dailymedi.com/detail.php?number=815413&thread=22r05
40,2017-02-03,영진약품메디포트고용량비타민D공동판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71138
41,2017-02-03,단독영진약품신약물질KL1333임상1상승인,http://news1.kr/articles/?2902427
42,2017-02-03,영진약품메디포트고용량비타민D공동판매계약,http://www.joseilbo.com/news/news_read.php?uid=315647&class=27&grp=
43,2017-02-03,영진약품메디포트비타민D공동판매,http://www.newstomato.com/ReadNews.aspx?no=729057
44,2017-02-05,영진약품첫신약임상착수,http://www.newstomato.com/ReadNews.aspx?no=729048
45,2017-02-06,특징주영진약품사흘만에날갯짓외인러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201702060917060576242_1/article.html
46,2017-02-06,영진약품미토콘드리아이상질환국내1상IND승인,http://medipana.com/news/news_viewer.asp?NewsNum=194883&MainKind=A&NewsKind=5&vCount=12&vKind=1
47,2017-02-06,영진약품합병후첫희귀질환치료제국내임상1상승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1451113
48,2017-02-06,영진약품멜라스증후군치료제임상1상승인,http://www.dailymedi.com/detail.php?number=815482&thread=22r05
49,2017-02-06,영진약품미토콘드리아이상질환치료제KL1333식약처임상1상승인,http://www.fnnews.com/news/201702061152409229
50,2017-02-06,영진약품멜라스증후군치료제1상승인,http://www.dt.co.kr/contents.html?article_no=2017020602109976029005
51,2017-02-06,영진약품미토콘드리아이상질환치료제임상승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71169
52,2017-02-07,오마이스탁KTG생명과학흡수합병영진약품르노삼성특별배당220억원삼성카드,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017020713213148715
53,2017-02-09,1석2조노리는영진약품CP강화,http://www.dailymedi.com/detail.php?number=815601&thread=22r05
54,2017-02-14,머크영진약품과글루코파지콩코르국내영업공동프로모션,http://www.asiatoday.co.kr/view.php?key=20170214010008601
55,2017-02-14,머크영진약품과글루코파지콩코르국내영업공동프로모션,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017021408461148147
56,2017-02-14,한국머크영진약품당뇨병치료제공동판매계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170214040300017&did=1195m
57,2017-02-14,머크영진약품과글루코파지콩코르국내영업공동프로모션,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203510
58,2017-02-14,머크영진약품글루코파지콩코르코프로모션,http://www.dailypharm.com/News/222095
59,2017-02-14,머크영진약품글루코파지콩코르공동프로모션계약,http://www.bosa.co.kr/news/articleView.html?idxno=2054804
60,2017-02-14,머크영진약품과글루코파지콩코르공동프로모션,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71280
61,2017-02-14,머크영진약품당뇨병치료제등코프로모션,http://www.kormedi.com/news/news/drug_dist/1221960_2906.html
62,2017-02-14,한국머크영진약품당뇨병고혈압치료제공동판매,http://www.sedaily.com/NewsView/1OC3B5KNX6
63,2017-02-14,한국머크영진약품과공동판촉계약체결,http://www.etnews.com/20170214000238
64,2017-02-14,머크영진약품글루코파지＆콩코르국내영업공동프로모션,http://www.mdtoday.co.kr/mdtoday/index.html?no=279253
65,2017-02-14,영진약품머크머크3개제품공동판매,http://www.ajunews.com/view/20170214190256602
66,2017-02-15,fnRASSI영진약품318오르며거래량증가,http://www.fnnews.com/news/201702151007235995
67,2017-02-15,한국머크영진약품과당뇨병치료제등공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=101951
68,2017-02-19,ST포토10km시상하는영진약품박수준사장,http://stoo.asiae.co.kr/news/naver_view.htm?idxno=2017021912435277882
69,2017-02-22,특징주영진약품외인매도에도이틀째기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201702220916430687111_1/article.html
70,2017-02-24,특징주영진약품급등세조만간기술수출,http://www.sporbiz.co.kr/news/articleView.html?idxno=80658
71,2017-02-24,상한가근접9000원돌파영진약품상한가치솟나주식분할모멘텀일성건설일성건설우후끈,http://www.g-enews.com/ko-kr/news/article/news_all/201702241415101374270_1/article.html
72,2017-02-24,특징주영진약품이상급등새로운소식없어예민한반응,http://biz.chosun.com/site/data/html_dir/2017/02/24/2017022401633.html
73,2017-02-24,오늘의상한가삼성화장품테마주영진약품上근접,http://www.etoday.co.kr/news/section/newsview.php?idxno=1460361
74,2017-02-24,마감SK하이닉스CS보고서에급락영진약품COPD치료제수출기대감,http://www.sporbiz.co.kr/news/articleView.html?idxno=80784
75,2017-02-27,특징주영진약품COPD기술수출기대에오름세지속,http://www.sporbiz.co.kr/news/articleView.html?idxno=81215
76,2017-02-27,국고처최승욱종목상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201702250024
77,2017-02-28,특징주영진약품외인매도딛고9000원돌파하나사흘연속↑,http://www.g-enews.com/ko-kr/news/article/news_all/201702280906370586092_1/article.html
78,2017-03-03,빅데이터MSI시장심리톱5삼성전자KT현대차삼성물산영진약품,http://www.newsis.com/view/?id=NISX20170303_0014740662&cID=10401&pID=10400
79,2017-03-06,코스피주가상승률높은종목은성지건설334영진약품289↑,http://www.dt.co.kr/contents.html?article_no=2017030502109958033004
80,2017-03-06,특징주영진약품외인러브콜하루만에날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201703060918030450579_1/article.html
81,2017-03-06,특징주영진약품강세COPD해외임상2상종료,http://www.sporbiz.co.kr/news/articleView.html?idxno=83029
82,2017-03-08,특징주영진약품외인매도에도사흘째상승랠리226↑,http://www.g-enews.com/ko-kr/news/article/news_all/201703080907590612078_1/article.html
83,2017-03-08,영진약품박수준대표재선임결의,http://www.dailypharm.com/News/222969
84,2017-03-08,영진약품박수준대표이사재선임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204179
85,2017-03-20,영진약품매출1931억135증가수출323증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204508
86,2017-03-20,국고처류태형문자상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703180080
87,2017-03-20,영진약품日에1815억규모의약품공급계약체결,http://www.sedaily.com/NewsView/1ODG1T3WTI
88,2017-03-20,영진약품공업18156억규모의약품공급계약체결,http://www.newsis.com/view/?id=NISX20170320_0014776550&cID=13001&pID=13000
89,2017-03-20,영진약품日사에1816억원항생제공급계약,http://www.edaily.co.kr/news/newspath.asp?newsid=04201686615865288
90,2017-03-20,영진약품공업1816억원규모의약품공급계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1469893
91,2017-03-21,영진약품日제약사와1815억규모공급계약체결,http://www.fntimes.com/paper/view.aspx?num=176194
92,2017-03-21,특징주영진약품일본제약사와공급계약체결에급등,http://www.sporbiz.co.kr/news/articleView.html?idxno=87874
93,2017-03-21,영진약품대규모공급계약에강세,http://www.sedaily.com/NewsView/1ODGFVYQ2M
94,2017-03-21,특징주영진약품日제약사와18156억의약품공급계약소식에↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01899126615865616
95,2017-03-21,특징주영진약품대규모공급계약체결급등,http://stock.hankyung.com/news/app/newsview.php?aid=2017032148426
96,2017-03-21,특징주영진약품1800억원규모공급계약체결소식에급등,http://biz.chosun.com/site/data/html_dir/2017/03/21/2017032100695.html
97,2017-03-21,fnRASSI영진약품003520현재702,http://www.fnnews.com/news/201703210909235901
98,2017-03-21,특징주영진약품1816억원규모의약품공급계약에강세,http://www.newstomato.com/ReadNews.aspx?no=739958
99,2017-03-21,특징주영진약품대규모판매공급계약체결9000원돌파,http://www.g-enews.com/ko-kr/news/article/news_all/201703210907229346c642673384_1/article.html
100,2017-03-21,특징주영진약품日제약사와1800억원규모수출계약강세,http://www.ebn.co.kr/news/view/882756
101,2017-03-21,특징주영진약품1800억규모공급계약강세,http://www.newspim.com/news/view/20170321000079
102,2017-03-21,특징주영진약품1800억원대공급계약체결에강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1470071
103,2017-03-21,HotLine영진약품일본제약사공급계약소식에급등,http://news.mk.co.kr/newsRead.php?&year=2017&no=190449
104,2017-03-21,영진약품대규모공급계약체결에상승세,http://www.newsprime.co.kr/news/article.html?no=368426
105,2017-03-21,특징주영진약품대규모수출계약에상승,http://www.viva100.com/main/view.php?key=20170321010007210
106,2017-03-21,특징주영진약품대규모의약품공급소식에강세,http://www.asiatoday.co.kr/view.php?key=20170321010013149
107,2017-03-21,특징주영진약품1800억공급계약소식강세,http://www.seoulfn.com/news/articleView.html?idxno=275102
108,2017-03-21,영진약품日제약사와1816규모항생제공급계약연장,http://www.mdtoday.co.kr/mdtoday/index.html?no=281706
109,2017-03-22,더벨영진약품1800억위탁생산추가계약마진은미미,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201703210100039660002446
110,2017-03-22,특징주영진약품외인러브콜닷새째상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201703220911015265c642673384_1/article.html
111,2017-03-22,특징주영진약품5거래일연속강세,http://www.sisaweek.com/news/articleView.html?idxno=88857
112,2017-03-24,특징주영진약품외인러브콜사흘만에날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201703240906268008c642673384_1/article.html
113,2017-03-27,특징주영진약품이틀째기지개외인매수주목,http://www.g-enews.com/ko-kr/news/article/news_all/201703270927249801c642673384_1/article.html
114,2017-04-04,fnRASSI영진약품003520현재685↑,http://www.fnnews.com/news/201704041350035255
115,2017-04-05,특징주영진약품주가신바람외인매수나흘째상승행진,http://www.g-enews.com/ko-kr/news/article/news_all/201704050907068829c642673384_1/article.html
116,2017-04-05,특징주영진약품강세신약기대감,http://stock.hankyung.com/news/app/newsview.php?aid=2017040559856
117,2017-04-05,특징주영진약품COPD신약기대에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=93352
118,2017-04-06,특징주영진약품닷새째상승세이어갈까외인은매도약보합,http://www.g-enews.com/ko-kr/news/article/news_all/201704060909107751c642673384_1/article.html
119,2017-04-06,영진약품아토피치료제유토마외용액23개월판매정지행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205008
120,2017-04-07,영진약품유토마외용액2등3곳제약제품행정처분,http://www.bosa.co.kr/news/articleView.html?idxno=2058519
121,2017-04-07,영진약품유토마외용액23개월판매정지등3곳행정처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=283206
122,2017-04-11,특징주영진약품외인러브콜주가하루만에날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201704110919099570c642673384_1/article.html
123,2017-04-12,빅데이터MSI시장심리톱5영진약품하나금융지주코스맥스크라운제과한전KPS,http://www.newsis.com/view/?id=NISX20170412_0014825646&cID=10401&pID=10400
124,2017-04-21,특징주영진약품주가힘겨루기외인은순매수확대,http://www.g-enews.com/ko-kr/news/article/news_all/201704210906505845c642673384_1/article.html
125,2017-04-25,특징주영진약품외인매수주목주가사흘만에날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201704250911272054c642673384_1/article.html
126,2017-04-27,영진약품공업1분기영업익27억전년比779↑,http://www.newsis.com/view/?id=NISX20170427_0014858869&cID=10401&pID=10400
127,2017-04-27,영진약품공업1분기영업익27억원779↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170427087700008&did=1195m
128,2017-04-27,영진약품공업1Q영업이익27억원전년比779↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02906086615900384
129,2017-04-27,ET투자뉴스2017년1분기실적발표영진약품공업전분기比영업이익순이익모두흑자전환,http://www.etnews.com/20170427000118
130,2017-04-27,영진약품공업1분기영업익27억1800만원전년비779증가,http://www.newstomato.com/ReadNews.aspx?no=749715
131,2017-04-27,영진약품1분기영업익271억전년비779↑,http://news.heraldcorp.com/view.php?ud=20170427000516
132,2017-04-27,영진약품공업1Q영업익27억원전년비779↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1485463
133,2017-04-27,실적발표영진약품공업아이센스녹십자엠에스,http://www.businesspost.co.kr/news/articleView.html?idxno=48140
134,2017-04-27,영진약품1분기영업익27억전년비779↑,http://www.ajunews.com/view/20170427162031893
135,2017-04-28,영진약품CP준수임원들의역할절대적,http://medipana.com/news/news_viewer.asp?NewsNum=198730&MainKind=A&NewsKind=5&vCount=12&vKind=1
136,2017-04-28,영진약품CP준수위한임원리더십교육실시,http://www.m-i.kr/news/articleView.html?idxno=308011
137,2017-04-28,영진약품CP준수에임원역할절대적,http://www.dailypharm.com/News/224943
138,2017-04-29,영진약품CP준수임원리더십교육실시,http://www.monews.co.kr/news/articleView.html?idxno=100864
139,2017-05-02,영진약품공업기술이전계약체결,http://www.newstomato.com/ReadNews.aspx?no=750397
140,2017-05-02,영진약품공업스웨덴업체와기술이전계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1486743
141,2017-05-02,영진약품스웨덴기업에기술이전계약체결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017050207414752492&outlink=1
142,2017-05-02,영진약품스웨덴제약사와기술이전계약체결,http://www.newspim.com/news/view/20170502000033
143,2017-05-02,영진약품공업스웨덴제약사에기술이전계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170502029200008&did=1195m
144,2017-05-02,영진약품스웨덴제약사와기술이전계약,http://biz.chosun.com/site/data/html_dir/2017/05/02/2017050200486.html
145,2017-05-02,영진약품스웨덴기업에기술이전계약체결,http://www.newsis.com/view/?id=NISX20170502_0014868366&cID=10434&pID=13000
146,2017-05-02,영진약품공업스웨덴제약사에기술이전계약체결,http://www.ebn.co.kr/news/view/890001
147,2017-05-02,공시영진약품스웨덴업체와신약기술이전계약체결,http://www.ajunews.com/view/20170502084747530
148,2017-05-02,영진약품공업스웨덴제약사와기술이전계약,http://www.sedaily.com/NewsView/1OFRL09JC4
149,2017-05-02,특징주영진약품기술수출계약소식에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170502040100008&did=1195m
150,2017-05-02,특징주영진약품스웨덴제약사에기술이전계약주가시동걸리나,http://www.g-enews.com/ko-kr/news/article/news_all/201705020902528088c642673384_1/article.html
151,2017-05-02,영진약품스웨덴에희귀질환약물기술수출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72535
152,2017-05-02,영진약품스웨덴회사에희귀질환약기술수출,http://medipana.com/news/news_viewer.asp?NewsNum=198799&MainKind=A&NewsKind=5&vCount=12&vKind=1
153,2017-05-02,영진약품기술수출계약호재에상승세,http://www.sedaily.com/NewsView/1OFRM1XCTO
154,2017-05-02,특징주영진약품강세스웨덴제약업체에기술수출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1486806
155,2017-05-02,영진약품공업스웨덴제약사에기술이전계약종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170502029251008&did=1195m
156,2017-05-02,특징주영진약품기술이전계약체결에상승,http://www.viva100.com/main/view.php?key=20170502010000416
157,2017-05-02,영진약품스웨덴에650억규모희귀약기술수출계약체결,http://www.dt.co.kr/contents.html?article_no=2017050202109976029001
158,2017-05-02,특징주영진약품기술이전계약체결소식에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01905686615924984
159,2017-05-02,영진약품스웨덴제약사와기술이전계약소식에오름세,http://www.newsprime.co.kr/news/article.html?no=373550
160,2017-05-02,영진약품공업스웨덴업체와기술이전계약체결,http://stock.hankyung.com/news/app/newsview.php?aid=2017050221766
161,2017-05-02,영진약품뉴로바이브KL1333기술수출계약,http://www.m-i.kr/news/articleView.html?idxno=308380
162,2017-05-02,영진약품공업12일임시주총개최,http://www.mt.co.kr/view/mtview.php?type=1&no=2017050209481859145&outlink=1
163,2017-05-02,특징주영진약품5700만달러규모기술이전계약소식에상승세,http://www.dailian.co.kr/news/view/630517/?sc=naver
164,2017-05-02,영진약품615억대기술수출체결,http://www.dailymedi.com/detail.php?number=818304&thread=22r05
165,2017-05-02,영진약품646억규모유전성희귀병신약물질기술수출,http://news1.kr/articles/?2983633
166,2017-05-02,영진약품스웨덴뉴로바이브와KL1333의글로벌라이센스협약체결,http://www.fnnews.com/news/201705021031081123
167,2017-05-02,영진약품스웨덴제약사에신약기술이전,http://www.kormedi.com/news/news/drug_dist/1223154_2906.html
168,2017-05-02,영진약품스웨덴기업에기술이전계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02653526615924984
169,2017-05-02,영진약품신약물질KL1333스웨덴제약사에기술이전,http://www.monews.co.kr/news/articleView.html?idxno=100961
170,2017-05-02,영진약품스웨덴제약사에신약기술이전계약체결,http://daily.hankooki.com/lpage/economy/201705/dh20170502165128138080.htm
171,2017-05-02,영진약품희귀질환신약스웨덴수출,http://www.hankyung.com/news/app/newsview.php?aid=2017050234321
172,2017-05-02,영진약품스웨덴제약사에희귀질환신약기술수출,http://www.rapportian.com/news/articleView.html?idxno=103579
173,2017-05-04,특징주영진약품외인사자확대기술이전계약모멘텀이어지나,http://www.g-enews.com/ko-kr/news/article/news_all/201705040912301609c642673384_1/article.html
174,2017-05-06,한미약품제약상장기업5월브랜드평판1위녹십자유한양행영진약품종근당順,http://www.ggilbo.com/news/articleView.html?idxno=368399
175,2017-05-08,특징주영진약품기술이전계약외인사자주가나흘째날갯짓,http://www.g-enews.com/ko-kr/news/article/news_all/201705080916193057c642673384_1/article.html
176,2017-05-08,fnRASSI영진약품003520현재542↑,http://www.fnnews.com/news/201705081005465635
177,2017-05-08,특징주영진약품스웨덴제약사에기술이전계약소식에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=103100
178,2017-05-08,fnRASSI영진약품003520현재588↑,http://www.fnnews.com/news/201705081311564792
179,2017-05-08,오마이스탁스웨덴제약업체와기술이전계약체결영진약품관매수세유입지속심텍,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017050813214111651
180,2017-05-11,특징주영진약품엿새째상승행진할까외인은매도주가는약보합,http://www.g-enews.com/ko-kr/news/article/news_all/2017051109162458c642673384_1/article.html
181,2017-05-16,특징주영진약품외인소폭팔자우위주가사흘만에반등,http://www.g-enews.com/ko-kr/news/article/news_all/201705160914584422c642673384_1/article.html
182,2017-05-18,영진약품1분기전년비매출51영업이익779증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206083
183,2017-05-19,특징주영진약품외인오락가락vs주가사흘째상승행진,http://www.g-enews.com/ko-kr/news/article/news_all/201705190913563508c642673384_1/article.html
184,2017-05-22,국고처류태형시청자문자상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201705200080
185,2017-05-24,특징주영진약품엿새째상승행진외인은팔고사고,http://www.g-enews.com/ko-kr/news/article/news_all/201705240913272592c642673384_1/article.html
186,2017-05-24,fnRASSI영진약품436오르며거래량증가,http://www.fnnews.com/news/201705241018200578
187,2017-05-24,특징주영진약품거래량급증세무슨일이,http://www.sporbiz.co.kr/news/articleView.html?idxno=108553
188,2017-05-25,특징주영진약품주가1만원돌파7거래일연속상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201705250903436643c642673384_1/article.html
189,2017-05-25,빅데이터MSI시장심리톱5삼성전기포스코현대미포조선롯데케미칼영진약품,http://www.newsis.com/view/?id=NISX20170525_0014918411&cID=10401&pID=10400
190,2017-05-26,영진약품제약산업지원정책기대감에8거래일연속상승,http://www.sedaily.com/NewsView/1OG2MJGD2O
191,2017-05-26,영진약품공업내달12일임시주총사명변경,http://view.asiae.co.kr/news/view.htm?idxno=2017052611382425115
192,2017-05-26,영진약품공업내달12일주주총회개최,http://www.mt.co.kr/view/mtview.php?type=1&no=2017052611401819349&outlink=1
193,2017-05-28,박수준영진약품사장신약성과이제시작2022년빅5도약,http://news.mk.co.kr/newsRead.php?&year=2017&no=356230
194,2017-05-29,특징주영진약품1만원선안착시도9거래일연속상승랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201705290913515203c642673384_1/article.html
195,2017-05-29,영진약품주가최고치등상승세,http://www.dailymedi.com/detail.php?number=819097&thread=22r05
196,2017-05-29,마감영진약품20조COPD치료제시장기대에강세LG전자갤럭시S8넘을G7개발착수,http://www.sporbiz.co.kr/news/articleView.html?idxno=110032
197,2017-05-30,특징주영진약품10거래일상승행진외인오락가락,http://www.g-enews.com/ko-kr/news/article/news_all/201705300923272024c642673384_1/article.html
198,2017-05-30,특징주영진약품20조COPD치료제시장기대에또강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=110142
199,2017-05-30,마감전략A2부7인의관심종목대공개메리츠종금증권영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017053016024128167
200,2017-05-30,마감미래에셋SK증권인수사실무근영진약품COPD치료제기대감에10일연속상승,http://www.sporbiz.co.kr/news/articleView.html?idxno=110462
201,2017-05-31,10거래일연속상승그래프그리는영진약품,http://www.mdtoday.co.kr/mdtoday/index.html?no=286843
202,2017-05-31,터치UpDown영진약품COPD치료제기대에10거래일연속상승,http://www.sedaily.com/NewsView/1OG4WP3WU2
203,2017-05-31,특징주영진약품COPD치료제기대에급등11일연속상승,http://www.sporbiz.co.kr/news/articleView.html?idxno=110557
204,2017-05-31,특징주영진약품COPD치료제기대에11거래일연속상승,http://www.g-enews.com/ko-kr/news/article/news_all/201705310927099705581e5800d6_1/article.html
205,2017-05-31,특징주영진약품치료제출시기술이전계약으로연일상승,http://www.dailian.co.kr/news/view/636723/?sc=naver
206,2017-05-31,fnRASSI영진약품003520현재928,http://www.fnnews.com/news/201705310944523810
207,2017-05-31,오픈토크영진약품,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002829809
208,2017-05-31,마감STX중공업매각기대감에상한가영진약품11일연속오름세,http://www.sporbiz.co.kr/news/articleView.html?idxno=110828
209,2017-05-31,영진약품의주가미스터리11일연속묻지마급등,http://stock.hankyung.com/news/app/newsview.php?aid=2017053125441
210,2017-06-01,특징주영진약품12거래일연속상승세,http://www.newspim.com/news/view/20170601000068
211,2017-06-01,특징주영진약품12일연속급등,http://www.g-enews.com/ko-kr/news/article/news_all/20170601092634981581e5800d6_1/article.html
212,2017-06-01,빅데이터MSI시장심리톱5포스코대림산업LG신세계영진약품,http://www.newsis.com/view/?id=NISX20170601_0014933013&cID=10401&pID=10400
213,2017-06-01,마감STX중공업매각기대감에이틀째급등영진약품12일연속강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=111352
214,2017-06-02,ET투자뉴스영진약품_13일만에하락반전현재352,http://www.etnews.com/20170602000043
215,2017-06-02,특징주영진약품너무올랐나13거래일만에하락,http://www.g-enews.com/ko-kr/news/article/news_all/201706020930231991581e5800d6_1/article.html
216,2017-06-02,특징주영진약품앗뜨거13일만에하락,http://www.sporbiz.co.kr/news/articleView.html?idxno=111472
217,2017-06-02,레고켐영진약품기술이전동참중소업체기지개,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706020039
218,2017-06-02,친절한바이오레고켐영진약품기술이전동참중소업체기지개,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706020067
219,2017-06-05,특징주영진약품이번엔치매관련주부각되면서강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=112148
220,2017-06-08,들썩이는영진약품왜토종식물산꼬리풀추출신약2상결과곧나온다,http://biz.chosun.com/site/data/html_dir/2017/06/08/2017060800427.html
221,2017-06-09,브랜드평판제약상장기업브랜드6월빅데이터분석1위한미약품2위영진약품3위셀트리온,http://www.futurekorea.co.kr/news/articleView.html?idxno=41016
222,2017-06-09,제약상장기업브랜드평판6월빅데이터1위한미약품2위영진약품3위셀트리온,http://www.betanews.net:8080/article/705179.html
223,2017-06-12,특징주영진약품주가팽팽외인은팔자닷새째상승행진이어갈까,http://www.g-enews.com/ko-kr/news/article/news_all/201706120908088315c642673384_1/article.html
224,2017-06-12,제약상장기업6월브랜드평판1위한미약품2위영진약품3위셀트리온,http://www.fntimes.com/paper/view.aspx?num=182639
225,2017-06-12,제약상장기업브랜드평판6월빅데이터분석1위한미약품2위영진약품3위셀트리온,http://www.ggilbo.com/news/articleView.html?idxno=379345
226,2017-06-12,영진약품공업영진약품으로상호변경,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061215232261031&outlink=1
227,2017-06-12,영진약품공업임시주총서상호영진약품으로변경건승인,http://view.asiae.co.kr/news/view.htm?idxno=2017061215260455395
228,2017-06-12,영진약품공업영진약품으로사명변경,http://www.edaily.co.kr/news/newspath.asp?newsid=03368566615961064
229,2017-06-13,국고처류태형종목상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706100082
230,2017-06-15,특징주영진약품주가팽팽외인은팔자,http://www.g-enews.com/ko-kr/news/article/news_all/201706150909162838c642673384_1/article.html
231,2017-06-15,특징주영진약품하락YPL001임상문제없나,http://www.sporbiz.co.kr/news/articleView.html?idxno=115342
232,2017-06-15,주목7인의선택넷마블게임즈영진약품등조건검색포착주21선,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017061514282144624
233,2017-06-15,주목7인의선택넷마블게임즈영진약품그리고대명코퍼레이션,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017061516174125841
234,2017-06-18,영진약품피레스파제네릭출시한발짝앞서,http://www.mdtoday.co.kr/mdtoday/index.html?no=288276
235,2017-06-19,특징주영진약품강세COPD치료제시장2025년141억달러,http://www.sporbiz.co.kr/news/articleView.html?idxno=116487
236,2017-06-19,국고처최승욱종목상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706170033
237,2017-06-20,영진약품아토피치료제유토마외용액26개월판매업무정지,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206924
238,2017-06-21,특징주영진약품15조시장COPD신약임상결과앞두고상승세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1505325
239,2017-06-21,호재맞은대화제약영진약품실적기대들썩,http://www.sisajournal-e.com/biz/article/170553
240,2017-06-23,특징주영진약품주가1만2000원탈환vs외인은매도,http://www.g-enews.com/ko-kr/news/article/news_all/201706230920033762c642673384_1/article.html
241,2017-06-27,특징주영진약품외인사자주가나흘만에꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201706270925058936c642673384_1/article.html
242,2017-06-29,영진약품피레스파첫제네릭우판권획득으로독점적지휘,http://www.mdtoday.co.kr/mdtoday/index.html?no=289379
243,2017-06-30,유가증권메모30일변경상장영진약품공업→영진약품상호변경등,http://news.hankyung.com/article/2017063037751
244,2017-07-06,특징주영진약품외인사자지속주가탄력받을까,http://www.g-enews.com/ko-kr/news/article/news_all/201707060922385479c642673384_1/article.html
245,2017-07-07,기업분석영진약품실적과기대감차이가계속되는기업,http://www.ekn.kr/news/article.html?no=298202
246,2017-07-07,그것이사고싶다현대모비스현대위아셀트리온삼성중공업휴온스글로벌영진약품그리고대유위니아,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017070715242141721
247,2017-07-10,국고처김종철종목상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707080025
248,2017-07-11,특징주영진약품주가1만1000원선지킬까외인오락가락,http://www.g-enews.com/ko-kr/news/article/news_all/201707110915313072c642673384_1/article.html
249,2017-07-12,특징주영진약품외인매수확대주가다시시동걸리나,http://www.g-enews.com/ko-kr/news/article/news_all/201707120916168012c642673384_1/article.html
250,2017-07-12,마감영진약품등제약바이오주코오롱생명과학인보사에무릎통증,http://www.sporbiz.co.kr/news/articleView.html?idxno=123858
251,2017-07-13,내일장멘토링내일투자중요체크관심주영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017071316115154702
252,2017-07-17,특징주영진약품주가꿈틀외인은팔고사고,http://www.g-enews.com/ko-kr/news/article/news_all/201707170917573096c642673384_1/article.html
253,2017-07-19,특징주영진약품1만1000원선안착닷새째상승랠리외인은팔고사고,http://www.g-enews.com/ko-kr/news/article/news_all/201707190917576903c642673384_1/article.html
254,2017-07-19,DataScore영진약품차입금의존도113로하락,http://www.ceoscoredaily.com/news/article.html?no=30729
255,2017-07-20,특징주영진약품외인사자확대주가상승랠리지속,http://www.g-enews.com/ko-kr/news/article/news_all/201707200918486820c642673384_1/article.html
256,2017-07-20,해외영업전문가박수준영진약품기술수출계약자신,http://www.businesspost.co.kr/news/articleView.html?idxno=54439
257,2017-07-21,영진약품단독으로아빌리파이용도특허무력화,http://medipana.com/news/news_viewer.asp?NewsNum=204473&MainKind=A&NewsKind=5&vCount=12&vKind=1
258,2017-07-22,아빌리파이양극성장애특허영진약품홀로깼다,http://www.dailypharm.com/News/229089
259,2017-07-24,유나이티드제약영진약품완제약수출이살길”,http://www.sisajournal-e.com/biz/article/171764
260,2017-07-25,영진약품아빌리파이양극성장애용도특허깼다,http://www.mdtoday.co.kr/mdtoday/index.html?no=291427
261,2017-07-25,더벨영진약품오산공장매각잔금172억수령지연,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707240100044530002652
262,2017-07-26,아주종목분석영진약품임상발표우려주가8하락,http://www.ajunews.com/view/20170726173250097
263,2017-07-27,특징주영진약품COPD신약임상에문제있나이틀째하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=129148
264,2017-07-27,영진약품2Q영업익12억45감소,http://www.asiae.co.kr/news/view.htm?idxno=2017072710350112070
265,2017-07-27,영진약품2분기영업이익12억전년비45↓,http://news.hankyung.com/article/2017072797816
266,2017-07-27,영진약품2Q영업익12억원전년比454↓,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072710423831607&outlink=1
267,2017-07-27,영진약품2분기영업익12억전년比454↓,http://www.newsis.com/view/?id=NISX20170727_0000052519&cID=10401&pID=10400
268,2017-07-27,영진약품2분기영업익12억전년비454↓,http://news.heraldcorp.com/view.php?ud=20170727000373
269,2017-07-27,영진약품상반기매출945억원전년대비38증가,http://www.dailypharm.com/News/229278
270,2017-07-27,영진약품2분기영업익12억원전년비454감소,http://www.newstomato.com/ReadNews.aspx?no=768361
271,2017-07-27,영진약품2Q영업익12억전년비454↓,http://www.newspim.com/news/view/20170727000104
272,2017-07-27,영진약품2분기영업익12억전년比454감소,http://www.kukinews.com/news/article.html?no=472393
273,2017-07-27,ET투자뉴스2017년2분기실적발표영진약품전분기比실적감소,http://www.etnews.com/20170727000418
274,2017-07-27,영진약품2017년2분기매출460억달성,http://www.m-i.kr/news/articleView.html?idxno=330085
275,2017-07-28,더벨1분기반짝영진약품2분기제자리로,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707270100053760003204
276,2017-07-28,특징주영진약품2분기실적부진에내림세,http://www.edaily.co.kr/news/newspath.asp?newsid=01928646615999112
277,2017-07-28,영진약품2분기실적부진주가도우울,http://www.newsprime.co.kr/news/article.html?no=383131
278,2017-07-31,특징주영진약품외인오락가락주가는꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201707310916227017c642673384_1/article.html
279,2017-07-31,특징주영진약품3거래일연속하락세벗어나소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=10466
280,2017-08-01,특징주영진약품3거래일연속하락세멈추고2거래일연속↑,http://www.econonews.co.kr/news/articleView.html?idxno=10475
281,2017-08-01,영진약품만성폐쇄성폐질환신약후보물질美임상2상완료,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170801156600008&did=1195m
282,2017-08-01,영진약품COPD신약후보물질美임상2a상완료,http://www.kukinews.com/news/article.html?no=473689
283,2017-08-01,유가증권시장공시메디플란트영진약품토니모리,http://news.mk.co.kr/newsRead.php?year=2017&no=516611
284,2017-08-01,마감영진약품COPD안정성및생체지표확인셀트리온헬스케어강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=131060
285,2017-08-01,영진약품COPD신약후보FDA임상2a상완료안전성확보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208322
286,2017-08-01,영진약품COPD신약후보물질YPL001美2a상완료,http://medipana.com/news/news_viewer.asp?NewsNum=204954&MainKind=A&NewsKind=5&vCount=12&vKind=1
287,2017-08-02,특징주영진약품COPD신약후보물질미국임상2상완료주가날았다,http://www.g-enews.com/ko-kr/news/article/news_all/201708020906026445c642673384_1/article.html
288,2017-08-02,특징주영진약품장초반20이상급등,http://www.mt.co.kr/view/mtview.php?type=1&no=2017080209033080666&outlink=1
289,2017-08-02,fnRASSI영진약품003520현재1859,http://www.fnnews.com/news/201708020907287165
290,2017-08-02,특징주영진약품만성폐쇄성폐질환신약후보물질美임상2상완료급등,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366616023384
291,2017-08-02,영진약품만성폐쇄성폐질환신약후보물질美임상2상완료소식에급등,http://www.sedaily.com/NewsView/1OJLFVIX43
292,2017-08-02,특징주영진약품신약후보임상성공기대에급등,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170802043800008&did=1195m
293,2017-08-02,특징주영진약품COPD신약안정성및생체지표확인에급등세,http://www.sporbiz.co.kr/news/articleView.html?idxno=131190
294,2017-08-02,특징주영진약품신약후보물질美임상2상결과수취장초반강세,http://www.asiae.co.kr/news/view.htm?idxno=2017080209164395523
295,2017-08-02,영진약품신약후보물질임상성공기대감에20급등,http://news.heraldcorp.com/view.php?ud=20170802000135
296,2017-08-02,특징주영진약품신약후보물질임상성공기대에급등,http://www.viva100.com/main/view.php?key=20170802010000612
297,2017-08-02,특징주영진약품신약후보물질임상성공기대에급등,http://www.viva100.com/main/view.php?key=20170802010000612
298,2017-08-02,특징주영진약품신약후보임상완료소식에급등,http://www.newsway.co.kr/view.php?tp=1&ud=2017080209235722638
299,2017-08-02,특징주영진약품신약임상시험성공기대감에급등,http://news.hankyung.com/article/2017080277546
300,2017-08-02,특징주영진약품신약임상실험완료에급등,http://www.seoulfn.com/news/articleView.html?idxno=284751
301,2017-08-02,특징주영진약품신약후보물질성공기대감에급등,http://www.newstomato.com/ReadNews.aspx?no=769553
302,2017-08-02,특징주영진약품미국서신약후보물질임상2상완료소식에16↑,http://www.econonews.co.kr/news/articleView.html?idxno=10488
303,2017-08-02,특징주영진약품신약후보물질임상성공기대감신고가,http://www.dailian.co.kr/news/view/651112/?sc=naver
304,2017-08-02,특징주영진약품급등신약후보임상성공기대감,http://www.ebn.co.kr/news/view/903788
305,2017-08-02,미국2a임상끝낸영진약품COPD신약은어떤약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045056
306,2017-08-02,영진약품COPD후보물질美임상2a완료,http://www.dailymedi.com/detail.php?number=821172&thread=22r05
307,2017-08-02,영진약품COPD신약후보물질美임상2a상결과안전성확보,http://www.mdtoday.co.kr/mdtoday/index.html?no=292192
308,2017-08-02,영진약품COPD신약개발기대감주가상승세,http://www.dailypharm.com/News/229467
309,2017-08-02,HotStock영진약품,http://news.hankyung.com/article/2017080203401
310,2017-08-03,빅데이터MSI시장심리톱5현대차영진약품두산현대중공업두산인프라코어,http://www.newsis.com/view/?id=NISX20170803_0000058452&cID=10401&pID=10400
311,2017-08-03,특징주영진약품3거래일연속상승세멈추고하락반전,http://www.econonews.co.kr/news/articleView.html?idxno=10502
312,2017-08-03,빅데이터MSI오전10시시장심리톱5현대차영진약품두산두산중공업현대중공업,http://www.newsis.com/view/?id=NISX20170803_0000058541&cID=10401&pID=10400
313,2017-08-04,특징주영진약품하락하루만에소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=10511
314,2017-08-04,특징주영진약품외인팔자주가는팽팽,http://www.g-enews.com/ko-kr/news/article/news_all/20170804092131603c642673384_1/article.html
315,2017-08-04,유나이티드영진약품연매출2000억원보이네”,http://www.sisajournal-e.com/biz/article/172228
316,2017-08-04,영진약품아빌리파이용도특허회피이제우판권만남았다,http://www.mdtoday.co.kr/mdtoday/index.html?no=292393
317,2017-08-04,그것이사고싶다영진약품캠시스LG디스플레이한국항공우주피엔티,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017080415320283671
318,2017-08-07,더벨영진약품COPD신약과연매력있나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201708040100008650000516
319,2017-08-07,특징주영진약품주가1만원선지킬까외인은공방,http://www.g-enews.com/ko-kr/news/article/news_all/201708070917442194c642673384_1/article.html
320,2017-08-07,특징주영진약품3거래일연속하락세060↓,http://www.econonews.co.kr/news/articleView.html?idxno=10530
321,2017-08-08,특징주영진약품2거래일연속상승세099↑,http://www.econonews.co.kr/news/articleView.html?idxno=10544
322,2017-08-08,영진약품재무구조개선목적214억규모유형자산양도,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208530
323,2017-08-09,영진약품평택토지매각지연금수령,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045306
324,2017-08-09,특징주영진약품하락하루만에상승반전131↑,http://www.econonews.co.kr/news/articleView.html?idxno=10558
325,2017-08-10,영진약품경기도평택토지매각잔여금수령,http://www.mdtoday.co.kr/mdtoday/index.html?no=292776
326,2017-08-10,빅데이터MSI시장심리톱5POSCO엔씨소프트삼성생명삼성엔지니어링영진약품,http://www.newsis.com/view/?id=NISX20170810_0000064194&cID=10401&pID=10400
327,2017-08-10,특징주영진약품2거래일연속하락세멈추고상승167↑,http://www.econonews.co.kr/news/articleView.html?idxno=10572
328,2017-08-10,특징주영진약품주가바닥찍었나외국인사자지속,http://www.g-enews.com/ko-kr/news/article/news_all/20170810091637369c642673384_1/article.html
329,2017-08-10,특징주영진약품급등세YPL001의한계는,http://www.sporbiz.co.kr/news/articleView.html?idxno=134131
330,2017-08-10,마감영진약품건강보험보장강화정책에강세LG디스플레이;하락,http://www.sporbiz.co.kr/news/articleView.html?idxno=134438
331,2017-08-11,빅데이터MSI시장심리톱5한화대한항공삼성생명한화생명영진약품,http://www.newsis.com/view/?id=NISX20170811_0000065454&cID=10401&pID=10400
332,2017-08-11,영진약품대규모바이오생산시설조성,http://www.newstomato.com/ReadNews.aspx?no=771553
333,2017-08-11,영진약품바이오산업단지화성시승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73991
334,2017-08-11,영진약품화성시에영진바이오일반산업단지승인,http://medipana.com/news/news_viewer.asp?NewsNum=205345&MainKind=A&NewsKind=5&vCount=12&vKind=1
335,2017-08-11,영진약품영진바이오일반산업단지화성시승인받아,http://www.fnnews.com/news/201708111454567650
336,2017-08-11,영진약품오산공장매각완료잔금172억원수령,http://www.sisajournal-e.com/biz/article/172604
337,2017-08-11,내일장멘토링내일투자중요체크관심주영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017081116300123525
338,2017-08-11,영진약품영진바이오일반산업단지승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=292993
339,2017-08-14,영진약품아토피치료제원료시험성적서조작,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045526
340,2017-08-14,영진약품공업유토마외용액2시험결과서거짓작성행정처분,http://www.kukinews.com/news/article.html?no=476655
341,2017-08-15,영진약품아토피치료제유토마연이은악재결과조작까지,http://news1.kr/articles/?3074523
342,2017-08-16,특징주영진약품주가꿈틀1만원선회복할까,http://www.g-enews.com/ko-kr/news/article/news_all/201708160917296119c642673384_1/article.html
343,2017-08-17,영진약품유토마외용액2시험결과거짓작성으로행정처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=293285
344,2017-08-17,특징주영진약품2거래일연속상승세멈추고하락099↓,http://www.econonews.co.kr/news/articleView.html?idxno=10620
345,2017-08-17,영진약품상반기매출945억전년비38영업익5증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208809
346,2017-08-17,그것이사고싶다코나아이KCC영진약품고려아연신라젠두산인프라코어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017081715233199465
347,2017-08-18,특징주영진약품반갑다외국인주가1만원시대다시열렸다,http://www.g-enews.com/ko-kr/news/article/news_all/201708180913396701c642673384_1/article.html
348,2017-08-22,특징주영진약품하락하루만에소폭상승주가롤러코스터,http://www.econonews.co.kr/news/articleView.html?idxno=10677
349,2017-08-22,특징주영진약품외인러브콜에1만원선지키나,http://www.g-enews.com/ko-kr/news/article/news_all/201708220914478311c642673384_1/article.html
350,2017-08-23,영진약품유토마외용액2임상시험1개월업무정지행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209003
351,2017-08-24,특징주영진약품주가기지개펴나외인러브콜확대,http://www.g-enews.com/ko-kr/news/article/news_all/201708240923412561c642673384_1/article.html
352,2017-08-25,특징주영진약품주가보합세숨고르기하나,http://www.econonews.co.kr/news/articleView.html?idxno=10714
353,2017-08-28,특징주영진약품3거래일연속상승세097↑,http://www.econonews.co.kr/news/articleView.html?idxno=10741
354,2017-08-28,공략9to10내일의키워드기로에선국내증시공략주영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082816220129011
355,2017-08-29,특징주영진약품4거래일연속상승세097↑,http://www.econonews.co.kr/news/articleView.html?idxno=10758
356,2017-08-29,내일장멘토링내일투자중요체크관심주영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082916263124062
357,2017-08-30,특징주영진약품4거래일연속상승세멈추고보합세,http://www.econonews.co.kr/news/articleView.html?idxno=10772
358,2017-08-30,단독영진약품80조시장통증치료제임상1상허가,http://www.newsprime.co.kr/news/article.html?no=386427
359,2017-08-31,영진약품통증치료제임상1상허가,http://www.sedaily.com/NewsView/1OJYQQW8H3
360,2017-08-31,특징주영진약품통증치료제임상1상허가외인매도vs주가는꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201708310912332969c642673384_1/article.html
361,2017-09-01,특징주영진약품주가바닥찍었나외인러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201709010919368957c642673384_1/article.html
362,2017-09-03,영진약품액상경구용비타민DD3베이스출시,http://news.kmib.co.kr/article/view.asp?arcid=0923808061&code=14130000&cp=nv
363,2017-09-05,특징주영진약품3거래일연속하락세멈추고소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=10844
364,2017-09-07,DataScore영진약품공업순익감소에도투자는두배이상늘려,http://www.ceoscoredaily.com/news/article.html?no=32014
365,2017-09-08,특징주영진약품주가바닥찍었나1만원선에서기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201709080922032148c642673384_1/article.html
366,2017-09-08,fnRASSI영진약품099오르며거래량증가,http://www.fnnews.com/news/201709081116029420
367,2017-09-11,영진약품코오롱제약피레스파제네릭우판권경쟁,http://www.mdtoday.co.kr/mdtoday/index.html?no=295272
368,2017-09-11,특징주영진약품3거래일연속상승세멈추고보합세,http://www.econonews.co.kr/news/articleView.html?idxno=10916
369,2017-09-12,특징주영진약품외인사자에주가상승행진,http://www.g-enews.com/ko-kr/news/article/news_all/201709120918521023c642673384_1/article.html
370,2017-09-14,영진약품유럽호흡기학회서COPD치료제YPL001비임상효능연구결과발표,http://www.fnnews.com/news/201709141056276635
371,2017-09-14,영진약품유럽호흡기학회서COPD물질연구발표,http://www.dailypharm.com/News/230881
372,2017-09-14,영진약품유럽호흡기학회서COPD물질연구발표,http://www.joseilbo.com/news/news_read.php?uid=335427&class=27&grp=
373,2017-09-14,영진약품유럽호흡기학회서COPD치료제비임상결과발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=295697
374,2017-09-14,영진약품ERS서COPD치료제비임상결과발표,http://www.monews.co.kr/news/articleView.html?idxno=105673
375,2017-09-22,특징주영진약품외인오락가락주가는힘겨루기,http://www.g-enews.com/ko-kr/news/article/news_all/201709220922068946c642673384_1/article.html
376,2017-09-25,특징주영진약품주가1만원선지킬까외인은팔자,http://www.g-enews.com/ko-kr/news/article/news_all/201709250913512720c642673384_1/article.html
377,2017-09-25,천식약싱귤레어우울증부작용영진약품호재,http://www.dailymedi.com/detail.php?number=822789&thread=22r05
378,2017-09-29,특징주영진약품반갑다외국인주가기지개펴나,http://www.g-enews.com/ko-kr/news/article/news_all/2017092909212513c642673384_1/article.html
379,2017-10-10,영진약품반기보고서정정공시금감원제재여부검토,http://www.nongaek.com/news/articleView.html?idxno=28955
380,2017-10-11,특징주영진약품외인러브콜주가사흘째꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201710110915018155c642673384_1/article.html
381,2017-10-11,영진약품상반기영업이익39억전년比5↑,http://www.newsworks.co.kr/news/articleView.html?idxno=142578
382,2017-10-12,영진약품반기사업보고서정정공시,http://www.nongaek.com/news/articleView.html?idxno=29109
383,2017-10-13,특징주영진약품외인순매수확대주가1만원선다시보이나,http://www.g-enews.com/ko-kr/news/article/news_all/201710130915497327c642673384_1/article.html
384,2017-10-13,영진약품프레지니우스카비아다멜엔주판매,http://medipana.com/news/news_viewer.asp?NewsNum=207915&MainKind=A&NewsKind=5&vCount=12&vKind=1
385,2017-10-13,영진약품프레지니우스카비신약아다멜엔판매계약및개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=297931
386,2017-10-16,특징주영진약품주가1만원지지선주목외인은팔자,http://www.g-enews.com/ko-kr/news/article/news_all/201710160916144879c642673384_1/article.html
387,2017-10-16,영진약품아다멜엔주판매계약체결,http://www.monews.co.kr/news/articleView.html?idxno=106492
388,2017-10-17,특징주영진약품2거래일연속하락세070↓,http://www.econonews.co.kr/news/articleView.html?idxno=11546
389,2017-10-18,특징주영진약품주가1만원다시탈환이번엔지지외인순매수주목,http://www.g-enews.com/ko-kr/news/article/news_all/20171018091733444c642673384_1/article.html
390,2017-10-18,특징주영진약품2거래일연속하락세멈추고상승반전,http://www.econonews.co.kr/news/articleView.html?idxno=11580
391,2017-10-20,특징주영진약품외인팔자주가1만원지지주목,http://www.g-enews.com/ko-kr/news/article/news_all/201710200917123102c642673384_1/article.html
392,2017-10-25,빅데이터MSI시장심리톱5SK하이닉스하나금융지주현대상선한온시스템영진약품,http://www.newsis.com/view/?id=NISX20171025_0000127566&cID=10401&pID=10400
393,2017-10-25,특징주영진약품주가1만원선지킬까외인사자소폭우위,http://www.g-enews.com/ko-kr/news/article/news_all/201710250922152546c642673384_1/article.html
394,2017-10-26,영진약품3분기영업이익9억원62감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171026086100008&did=1195m
395,2017-10-26,영진약품3Q영업익8억9300만원전년比623↓,http://www.asiae.co.kr/news/view.htm?idxno=2017102611050165899
396,2017-10-26,영진약품3분기영업익9억전년比623↓,http://www.newsis.com/view/?id=NISX20171026_0000129185&cID=10401&pID=10400
397,2017-10-26,영진약품3분기영업익9억원전년比62감소,http://biz.chosun.com/site/data/html_dir/2017/10/26/2017102601443.html
398,2017-10-26,공시영진약품3Q영업익8억9300만원전년동기比623,http://www.newsway.co.kr/view.php?tp=1&ud=2017102611163693080
399,2017-10-26,영진약품3분기영업이익8억9300만원전년比62감소,http://news.hankyung.com/article/2017102647396
400,2017-10-26,영진약품3분기영업익9억작년보다62감소,http://www.newstomato.com/ReadNews.aspx?no=784344
401,2017-10-26,영진약품89억전년비623↓,http://news.heraldcorp.com/view.php?ud=20171026000588
402,2017-10-26,영진약품3분기영업익9억원전년比62감소,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102610082260039&outlink=1
403,2017-10-26,영진약품3분기영업익8억9300만원전년比623↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1554397
404,2017-10-26,영진약품3분기영업익8억9300만원전년비623↓,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017102614002639900
405,2017-10-26,영진약품3Q영업익9억전년比62↓,http://www.edaily.co.kr/news/newspath.asp?newsid=03122566616096856
406,2017-10-26,공시영진약품3분기영업익8억9천만원전년比62↓,http://www.viva100.com/main/view.php?key=20171026010008266
407,2017-10-26,실적발표보령제약영진약품레드캡투어,http://www.businesspost.co.kr/BP?command=article_view&num=62195
408,2017-11-03,특징주영진약품외인순매수강화주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201711030917112062c642673384_1/article.html
409,2017-11-07,국고처박문환종목상담영진약품003520,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711040023
410,2017-11-08,영진약품COPD신약글로벌2a임상시험성공,http://medipana.com/news/news_viewer.asp?NewsNum=209350&MainKind=A&NewsKind=5&vCount=12&vKind=1
411,2017-11-08,영진약품YPL001글로벌임상성공,http://www.newstomato.com/ReadNews.aspx?no=787097
412,2017-11-08,특징주영진약품만성폐쇄성폐질환치료신약임상2a성공주가탄력,http://www.g-enews.com/ko-kr/news/article/news_all/20171108131432577c642673384_1/article.html
413,2017-11-08,영진약품COPD치료신약글로벌2a임상시험성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=300888
414,2017-11-08,영진약품COPD치료신약미FDA임상2a시험종료,http://www.fnnews.com/news/201711081435463988
415,2017-11-08,영진약품COPD치료신약YPL001임상성공,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75441
416,2017-11-08,영진약품COPD치료신약YPL001글로벌2a상성공,http://www.dt.co.kr/contents.html?article_no=2017110802109976029009&ref=naver
417,2017-11-08,영진약품COPD신약글로벌임상2a상성공,http://www.monews.co.kr/news/articleView.html?idxno=107524
418,2017-11-08,영진약품만성폐쇄성폐질환신약보고서FDA접수,http://www.kpinews.co.kr/news/articleView.html?idxno=58852
419,2017-11-09,특징주영진약품주가반전주목만성폐쇄성폐질환치료신약임상2a성공,http://www.g-enews.com/ko-kr/news/article/news_all/201711090912003982c642673384_1/article.html
420,2017-11-09,김용환의대박차트큐리언트115180영진약품003520,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003005797
421,2017-11-09,영진약품만성폐쇄성질환신약美FTA임상성공,http://www.newsworks.co.kr/news/articleView.html?idxno=147900
422,2017-11-15,특징주영진약품주가상승행진꿋꿋vs외인은팔자,http://www.g-enews.com/ko-kr/news/article/news_all/201711150916304656c642673384_1/article.html
423,2017-11-15,특징주영진약품3거래일연속상승세350↑,http://www.econonews.co.kr/news/articleView.html?idxno=12574
424,2017-11-20,특징주영진약품만성폐쇄성질환신약글로벌임상성공라이선스아웃기대↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01915526616127688
425,2017-11-21,더벨영진약품3년연속이익률2흑역사위기,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201711200100034090002103
426,2017-11-21,특징주영진약품주가1만원선지킬까외인은팔자,http://www.g-enews.com/ko-kr/news/article/news_all/201711210915468354c642673384_1/article.html
427,2017-11-21,영진약품만성폐쇄성폐질환신약물질발표이후주가상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=302328
428,2017-11-26,동아에스티영진약품신풍제약자디앙특허도전실패,http://www.mdtoday.co.kr/mdtoday/index.html?no=302835
429,2017-12-01,특징주영진약품주가탄력받을까외인러브콜지속,http://www.g-enews.com/ko-kr/news/article/news_all/201712010922005799c642673384_1/article.html
430,2017-12-01,특징주영진약품중국수입관세대폭낮춰약품공급부각강세,http://www.fnnews.com/news/201712010943272272
431,2017-12-01,특징주영진약품中관세인하천연물신약진출기대↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02214006616154256
432,2017-12-01,중국재정부소비재수입관세인하소식에영진약품강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=303525
433,2017-12-01,수급골든타임실시간수급시그널종목영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017120111021234763
434,2017-12-04,영진약품식약처우판권결정부당행정심판청구,http://www.dailypharm.com/News/234137
435,2017-12-05,영진약품우판권결정관련식약처에행정심판청구,http://www.mdtoday.co.kr/mdtoday/index.html?no=303859
436,2017-12-05,영진약품코오롱제약특발성폐섬유증치료제시장정조준,http://www.mdtoday.co.kr/mdtoday/index.html?no=303850
437,2017-12-05,영진약품박수준대표이사은탑산업훈장수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212788
438,2017-12-05,문대통령박수준영진약품대표이사에게은탑산업훈장수여,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20171205115600013&did=1196m
439,2017-12-05,문대통령박수준영진약품대표이사에게은탑산업훈장수여,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20171205115800013&did=1196m
440,2017-12-05,문대통령영진약품공업대표이사에은탑산업훈장수여,http://www.newsis.com/view/?id=NISI20171205_0013618182
441,2017-12-05,문대통령영진약품공업대표이사에은탑산업훈장수여,http://www.newsis.com/view/?id=NISI20171205_0013618183
442,2017-12-05,문대통령영진약품공업대표이사에은탑산업훈장수여,http://www.newsis.com/view/?id=NISI20171205_0013618181
443,2017-12-06,내일장멘토링中관세인하에낙폭과대까지관심주영진약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017120616282116807
444,2017-12-07,완주봉동읍영진약품사랑의연탄나눔행사,http://www.domin.co.kr/news/articleView.html?idxno=1177099
445,2017-12-13,특징주영진약품외국인순매수강화주가에단비,http://www.g-enews.com/ko-kr/news/article/news_all/201712130918523734c642673384_1/article.html
446,2017-12-21,특징주영진약품외인오락가락주가는공방,http://www.g-enews.com/ko-kr/news/article/news_all/201712210914419390c642673384_1/article.html
447,2017-12-29,영진약품셀트리온헬스케어등45개사주식2018년1월의무보호예수해제,http://www.g-enews.com/ko-kr/news/article/news_all/20171229135913466c642673384_1/article.html
448,2017-12-29,영진약품등45개사주식오는1월의무보호예수해제,http://www.ajunews.com/view/20171229152346484
